Depsipeptide (FR901228) Enhances the Cytotoxic Activity of TRAIL by Redistributing TRAIL Receptor to Membrane Lipid Rafts
Open Access
- 1 April 2005
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 11 (4), 542-552
- https://doi.org/10.1016/j.ymthe.2004.12.008
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanomaCancer Gene Therapy, 2003
- Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosisHepatology, 2003
- ApoptosisCell, 2002
- Suppression of Tumor Growth Following Intralesional Therapy with TRAIL Recombinant AdenovirusMolecular Therapy, 2001
- Adenovirus-mediated interferon-β gene therapy suppresses growth and metastasis of human prostate cancer in nude miceCancer Gene Therapy, 2001
- CD95 Signaling via Ceramide-rich Membrane RaftsJournal of Biological Chemistry, 2001
- ADENOVIRUS MEDIATED CYTOSINE DEAMINASE GENE TRANSDUCTION AND 5-FLUOROCYTOSINE THERAPY SENSITIZES MOUSE PROSTATE CANCER CELLS TO IRRADIATIONJournal of Urology, 2000
- Gene therapy for cancerEuropean Journal Of Cancer, 1999
- Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancerCancer Gene Therapy, 1999
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993